Sterling Capital Management’s Regeneron Pharmaceuticals REGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$2.25M Buy
4,287
+615
+17% +$323K 0.03% 353
2025
Q1
$2.33M Buy
3,672
+747
+26% +$474K 0.04% 320
2024
Q4
$2.08M Sell
2,925
-297
-9% -$212K 0.03% 396
2024
Q3
$3.39M Buy
+3,222
New +$3.39M 0.04% 283
2019
Q3
$377K Buy
1,358
+42
+3% +$11.7K ﹤0.01% 783
2019
Q2
$412K Sell
1,316
-15,901
-92% -$4.98M ﹤0.01% 775
2019
Q1
$7.07M Buy
17,217
+15,594
+961% +$6.4M 0.07% 208
2018
Q4
$606K Sell
1,623
-9
-0.6% -$3.36K 0.01% 713
2018
Q3
$659K Sell
1,632
-10
-0.6% -$4.04K 0.01% 751
2018
Q2
$566K Buy
1,642
+359
+28% +$124K 0.01% 741
2018
Q1
$442K Sell
1,283
-6,511
-84% -$2.24M ﹤0.01% 770
2017
Q4
$2.93M Sell
7,794
-5,939
-43% -$2.23M 0.03% 338
2017
Q3
$6.14M Sell
13,733
-3,671
-21% -$1.64M 0.06% 223
2017
Q2
$8.55M Sell
17,404
-133
-0.8% -$65.3K 0.08% 194
2017
Q1
$6.8M Buy
17,537
+105
+0.6% +$40.7K 0.06% 219
2016
Q4
$6.4M Sell
17,432
-644
-4% -$236K 0.06% 218
2016
Q3
$7.27M Buy
18,076
+848
+5% +$341K 0.07% 203
2016
Q2
$6.02M Hold
17,228
0.06% 226
2016
Q1
$6.21M Buy
17,228
+449
+3% +$162K 0.06% 224
2015
Q4
$9.11M Sell
16,779
-1,127
-6% -$612K 0.08% 181
2015
Q3
$8.33M Hold
17,906
0.07% 181
2015
Q2
$9.13M Sell
17,906
-650
-4% -$332K 0.08% 128
2015
Q1
$8.38M Sell
18,556
-1,360
-7% -$614K 0.07% 128
2014
Q4
$8.17M Sell
19,916
-5,246
-21% -$2.15M 0.07% 128
2014
Q3
$9.07M Sell
25,162
-4,730
-16% -$1.71M 0.11% 121
2014
Q2
$8.44M Sell
29,892
-2,839
-9% -$802K 0.07% 129
2014
Q1
$9.83M Sell
32,731
-4,469
-12% -$1.34M 0.08% 131
2013
Q4
$10.2M Buy
+37,200
New +$10.2M 0.09% 131